Korro Bio Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2019)
Status: Acquired by Frequency Therapeutics (2023)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Korro Bio (0) Acquired (1)

fx-322 (6 trials)

Drugs in Phase 1 Trials (1)

Key: Korro Bio (0) Acquired (1)

fx-345 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 7
  • # of Trial APIs: 2